Loading chat...
CA SB1442
Bill
Status
Engrossed
5/22/2024
Primary Sponsor
Rosilicie Ochoa Bogh
Click for details
AI Summary
- Authorizes the California Health and Human Services Agency (CHHSA) to enter into partnerships for manufacturing or purchasing FDA-approved point-of-care tests for fentanyl
- Allows partnered entities authorized under federal or state law to develop, manufacture, or distribute fentanyl point-of-care tests
- Defines "point-of-care test for fentanyl" as a test to detect fentanyl consumption, including fentanyl test strips used on urine samples
- Expands existing California Affordable Drug Manufacturing Act authority to include fentanyl testing products alongside over-the-counter naloxone products
Legislative Description
Point-of-care tests for fentanyl.
Last Action
August 15 hearing: Held in committee and under submission.
8/15/2024
Committee Referrals
Appropriations6/12/2024
Health6/3/2024
Appropriations4/11/2024
Health2/29/2024
Rules2/16/2024
Full Bill Text
No bill text available